$3.98
0.5214.88%
Last update: Nov 6, 4:00 PM
Passage Bio Inc (PASG) Stock Price, Quote, News & History
PASGNASDAQ
Passage Bio Inc (NASDAQ: PASG) announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT-D clinical trial...
You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.
Other companies in Passage Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Passage Bio has a consensus price target of $14.00.
The stock price for Passage Bio (NASDAQ: PASG) is $3.32 last updated November 3, 2026 at 9:21 AM EST.
There are no upcoming dividends for Passage Bio.
Passage Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Passage Bio.
Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to...
